Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Temozolomide × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 22 Glioma 12 Sarcoma, Ewing 7 Brain Neoplasms 7 Gliosarcoma 6 Astrocytoma 6 Sarcoma 4 Rhabdomyosarcoma 4 Recurrence 3 Osteosarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Ependymoma 3 Diffuse Intrinsic Pontine Glioma 3 Small Cell Lung Carcinoma 2 Neuroblastoma 2 Lymphoma, Follicular 2 Lymphoma 2 Desmoplastic Small Round Cell Tumor 2 Colorectal Neoplasms 2 Wilms Tumor 1 Somatostatinoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡